Novel(US)
United States
- Overland Park, Kansas
- 29/05/2024
- Pre Series A
- $15,000,000
Novel's fintech funding platform breaks down the traditional growth barriers faced by today’s B2B software companies. Their tech-first approach makes it easy for customers to leverage future recurring revenue for immediate access to non-dilutive capital. Paired with online data-driven insights and curated resources, the Novel platform empowers entrepreneurs to capitalize on their momentum.
- Industry Financial Services
- Website https://novelcapital.com/
- LinkedIn https://www.linkedin.com/company/novelcapital/
Related People
Carlos AntequeraCo Founder
United States -
Kansas City Metropolitan Area
Fintech CEO, early-stage investor and advisor to technology companies. Seasoned technology entrepreneur with experience managing all aspects of a fast-growing start-up: Raising angel and institutional investment, business modeling and strategy, engineering, operations, product management, marketing, customer service, finance and corporate development. I serve in technology company boards and enjoy mentoring up-and-coming entrepreneurs.
Key Areas of expertise: Revenue-Based Financing, Early Stage Investing, EdTech, Talent Management, Enterprise Software Development, Product Management, M&A, Corporate Development Strategy, Private Equity, B2B Sales and Marketing.
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)